Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom.

ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan.

Immunocore Ltd., part of Immunocore Holdings Plc, is a company headquartered in Oxon, UK. The firm develops and commercializes transformative medicines for cancer, infection and autoimmune disease. It was founded in 2007. Bahija Jallal is the current CEO of the firm.\nThe company says this about itself: Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, autoimmune, and infectious disease. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs.

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company' s business is: - Health care; - Life-saving products derived from human plasma; - Pharmaceuticals and diagnostics essential to health; - Cell culture reagents for the pharmaceutical industry; - Veterinary vaccines and diagnostics to protect livestock and companion animals.

ISARIC - International Severe Acute Respiratory and Emerging Infection Consortium - is a global initiative aiming to ensure that clinical researchers have the open access protocols and data-sharing processes needed to facilitate a rapid response to emerging diseases that may turn into epidemics or pandemics.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Immune Design Corp. (IDC) uses breakthrough technology to develop safe and effective vaccines and therapeutics, with emphasis on the prevention and treatment of infectious disease. This goal is being achieved through dedicated research aimed towards a greater understanding of the immune system, and by developing a new generation of immune-based products for the pharmaceutical industry. IDC is passionate about its mission to alleviate human suffering and pursues this goal with high energy and an unsurpassed standard of excellence

Ningbo Beautiful Life Med Biological Tech Co. Ltd. is a private company headquartered in China. The firm provides healthcare IT services.

Shanghai Longyao Biotech Co., Ltd. engages in the provision of health management services. It focuses on the innovative and development of biotechnology such as tumor immune cell technology,\nstem cell technology, cell storage technology, and anti-aging technology. Its business scope includes\ntechnology development, technical consulting, technology transfer, and technical services of biotechnology; and import and export of goods and technology. The company was founded on September 16, 2013 and is headquartered in Shanghai, China.,

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases. The company's treatment aims to stimulate the immune system to recognize and fight cancer cells. Its goal is to treat cancers with novel combinations utilizing its unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines, and adjuvants. In addition to a broad portfolio, the company has an accomplished team of scientists, novel technology platforms, and fully-integrated end-to-end capabilities from discovery to GMP manufacturing. It was established in 1994 and is headquartered in Lexington, Massachusetts.

Shenzhen Binder Biotechnology Co., Ltd., established on 2015-06-11, Business scope includes general business items:Technical development of biological products;Technology development of biotechnology products;Sales of bioengineering products and technology transfer of research and development achievements of related projects,Technical service and technical consultation.(All of the above are related to the law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:

Xiangxue Pharmaceutical Co., Ltd. develops pharmaceutical products, Chinese herbal compound medicine, biomedical engineering product, functional drink, healthy food and herbal planting. Its products include more than 80 kinds of medicine, which fall into four categories of oral liquid, tablet, capsule and pellet. The company was founded by Wang Yonghui on December 16, 1997 and is headquartered in Guangzhou, China.

Xiangxue Life Science Technology (Guangdong) Co., Ltd., established on 2020-12-23, Business scope includes general items:R&D and application of cell technology;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Drug import and export;pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Beijing Gene Qiming Biotechnology Co., Ltd., established on 2015-12-25, Business scope includes technology promotion,technology development,technology transfer,technical consulting,Technical Services;Medical Research;Undertake the exhibition;Conference Services(No board and lodging);market survey;Enterprise Management Services;Import and export,Technology Import and Export,Agent import and export;Sales of medical devices(Ι,Class II),daily necessities,electronic product;Biotechnology Research and Development.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.

MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.